PPARα alleviates iron overload‐induced ferroptosis in mouse liver |
| |
Authors: | Guowei Xing Lihua Meng Shiyao Cao Shenghui Liu Jiayan Wu Qian Li Wendong Huang Lisheng Zhang |
| |
Affiliation: | 1. College of Veterinary Medicine/College of Biomedicine and Health, Huazhong Agricultural University, Wuhan China ; 2. Hubei Hongshan Laboratory, Wuhan China ; 3. State Key Laboratory of Kidney Diseases, Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, National Clinical Research Center for Kidney Diseases, Beijing China ; 4. Department of Diabetes Complications and Metabolism, Beckman Research Institute of City of Hope, Duarte CA, USA |
| |
Abstract: | Ferroptosis is an iron‐dependent form of non‐apoptotic cell death implicated in liver, brain, kidney, and heart pathology. How ferroptosis is regulated remains poorly understood. Here, we show that PPARα suppresses ferroptosis by promoting the expression of glutathione peroxidase 4 (Gpx4) and by inhibiting the expression of the plasma iron carrier TRF. PPARα directly induces Gpx4 expression by binding to a PPRE element within intron 3. PPARα knockout mice develop more severe iron accumulation and ferroptosis in the liver when fed a high‐iron diet than wild‐type mice. Ferrous iron (Fe2+) triggers ferroptosis via Fenton reactions and ROS accumulation. We further find that a rhodamine‐based "turn‐on" fluorescent probe(probe1) is suitable for the in vivo detection of Fe2+. Probe1 displays high selectivity towards Fe2+, and exhibits a stable response for Fe2+ with a concentration of 20 μM in tissue. Our data thus show that PPARα activation alleviates iron overload‐induced ferroptosis in mouse livers through Gpx4 and TRF, suggesting that PPARα may be a promising therapeutic target for drug discovery in ferroptosis‐related tissue injuries. Moreover, we identified a fluorescent probe that specifically labels ferrous ions and can be used to monitor Fe2+ in vivo. |
| |
Keywords: | Ferroptosis, Gpx4, Liver, PPARα , TRF |
|
|